Literature DB >> 4005272

Flux of palmitate through the peroxisomal and mitochondrial beta-oxidation systems in isolated rat hepatocytes.

J Kondrup, P B Lazarow.   

Abstract

Peroxisomes catalyze the beta-oxidation of fatty acids but their quantitative role in fatty acid catabolism in the intact hepatocyte is not yet clarified. In the present study peroxisomal beta-oxidation of [1-14C]palmitate was quantitated in hepatocytes without the use of metabolic inhibitors. It was assumed that acetyl-CoA formed by peroxisomal beta-oxidation enters the cytosolic pool of acetyl-CoA, whereas that from mitochondrial beta-oxidation enters the mitochondrial pool. The labeling of the two acetyl-CoA pools was assessed by measuring the incorporation of radioactivity into cholesterol (from cytosolic acetyl-CoA) and CO2 (from mitochondrial acetyl-CoA). The system was calibrated with [1-14C]acetate and [1-14C]butyrate because butyrate undergoes beta-oxidation only in mitochondria, whereas acetate forms acetyl-CoA primarily in the cytosol. The labeling ratio, [( 14C]cholesterol X 100)/[( 14C]cholesterol + [14C]CO2), reflects the site of formation of acetyl-CoA. This ratio was 0.51 for butyrate, 1.39 for acetate and 0.79 for palmitate. The difference between palmitate and butyrate was statistically significant (P less than 0.02). This indicates that not all of the palmitate was oxidized in mitochondria. By linear interpolation it was estimated that approximately 32% of the [1-14C]palmitate oxidation began in peroxisomes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005272     DOI: 10.1016/0005-2760(85)90041-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  Measurement of the rates of acetyl-CoA hydrolysis and synthesis from acetate in rat hepatocytes and the role of these fluxes in substrate cycling.

Authors:  B Crabtree; M J Gordon; S L Christie
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

2.  Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.

Authors:  J M Street; H Singh; A Poulos
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

Review 3.  The inborn errors of mitochondrial fatty acid oxidation.

Authors:  C Vianey-Liaud; P Divry; N Gregersen; M Mathieu
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 4.  The role of peroxisomes in mammalian cellular metabolism.

Authors:  P B Lazarow
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 5.  Zellweger syndrome: biochemical procedures in diagnosis, prevention and treatment.

Authors:  R B Schutgens; R J Wanders; H S Heymans; A W Schram; J M Tager; G Schrakamp; H van den Bosch
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

6.  Labeled oxidation products from [1-14C], [U-14C] and [16-14C]-palmitate in hepatocytes and mitochondria.

Authors:  C Chatzidakis; D A Otto
Journal:  Lipids       Date:  1987-09       Impact factor: 1.880

7.  Total and peroxisomal oxidation of various saturated and unsaturated fatty acids in rat liver, heart and m. quadriceps.

Authors:  F A Reubsaet; J H Veerkamp; J M Trijbels; L A Monnens
Journal:  Lipids       Date:  1989-11       Impact factor: 1.880

8.  In Vitro Monitoring of the Mitochondrial Beta-Oxidation Flux of Palmitic Acid and Investigation of Its Pharmacological Alteration by Therapeutics.

Authors:  Renata Murgasova; Ester Tor Carreras; Julien Bourgailh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

9.  On the estimation of alternative pathways of fatty acid oxidation in the liver in vivo.

Authors:  R Rognstad
Journal:  Bull Math Biol       Date:  1995-03       Impact factor: 1.758

10.  Estimation of peroxisomal and mitochondrial fatty acid oxidation in rat hepatocytes using tritiated substrates.

Authors:  R Rognstad
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.